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Background: Here we report the clinical and molecular characterization of two Xp11.22 deletions including
SHROOM4 and CLCN5 genes. These deletions appeared in the same X chromosome of the same patient.
Results: The patient is a six-year-old boy who presented hydrocephalus, severe psychomotor and growth retardation,
facial dysmorphism and renal proximal tubulopathy associated with low-molecular-weight proteinuria, hypercalciuria,
hyperaminoaciduria, hypophosphatemia and hyperuricemia. Standard and high resolution karyotypes showed a 46,XY
formula. Array-CGH revealed two consecutive cryptic deletions in the region Xp11.22, measuring respectively 148 Kb
and 2.6 Mb. The two deletions were inherited from the asymptomatic mother.
Conclusions: Array-CGH allowed us to determine candidate genes in the deleted region. The disruption and partial loss
of CLCN5 confirmed the diagnostic of Dent disease for this patient. Moreover, the previously described involvement of
SHROOM4 in neuronal development is discussed.
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X-linked transmission is a particular mode of transmission
as the X chromosome is present as two copies in females
but only as one copy in males. Thus, the consequences of
X chromosome anomaly are much more common in males
than females. Intellectual disability (ID) is defined as a glo-
bal deficiency in cognitive function (IQ < 70) with an onset
during childhood and associated with a diminished ability
to adapt to the daily demands of a normal social environ-
ment. ID occurs in 1-3% of the general population [1]. Over
10-12% of all cases of ID are thought to be X-linked
(XLMR) [2,3], which can be subdivided into syndromic
forms (S-XLMR), and non-syndromic forms (NS-XLMR).
It is known that up to 100 X-chromosomal genes could* Correspondence: narjes.guediche@yahoo.fr
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[4-6]. Indeed, more than 300 X-linked protein-coding
genes are expressed in brain tissue, suggesting that many
XLMR genes remain to be identified [3]. Interstitial dele-
tion within the short arm of X chromosome is an uncom-
mon chromosome structural abnormality that has been
studied essentially by conventional cytogenetic techniques.
So far, 11 cases of Xp11.22 deletions concerning 4 families
have been described [7-10]. These patients had a unique de-
letion, often associated with autism spectrum disorders [7].
None of them have been described with Dent disease
(OMIM number #300009) which is an X-linked inherited
renal condition characterized by proteinuria, hypercalciuria
and hyperphosphaturia, kidney stones, and in some cases,
kidney failure [11-13]. Here we report the first clinical de-
scription and molecular characterization using array-CGH
of a patient presenting two maternally inherited interstitial
deletions of Xp11.22 in the same chromosome associated
with severe psychomotor retardation and Dent disease.al. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Standard and high resolution karyotypes on cultured
peripheral lymphocytes showed a 46,XY formula for the
patient. FISH analyses of subtelomeric regions were
normal. The use of array-CGH (180 K) revealed two
consecutive deletions in the region Xp11.22, measuring
respectively 148 Kb and 2.6 Mb and including 2 genes
for the first deletion and 23 genes for the second dele-
tion (Figure 1A, B and Table 1). These results were con-
firmed with a 244 K analysis. Analyses did not reveal
other significant variations (gain or loss) on the other
chromosomes. BAC clones RP11-519 N18 and RP11-
637B23 did not give any signal on chromosome X while
BAC clones RP11-122 F2 and RP11-258C19 gave a sig-
nal on chromosome X (Figure 2A, C). The family inves-
tigation showed that the two deletions were inherited
from the mother, asymptomatic (Figure 2B, D).
Concerning the couple’s second pregnancy, fetal cytogen-
etic analysis performed on trophoblast cells at 12 weeks of
gestation showed a 46,XY formula. FISH analysis showed
that the male fetus had also inherited the two maternal de-
letions from the mother. According to the French law, the
parents decided to terminate the pregnancy. No autopsy
was performed.Figure 1 Chromosome X profile from array-CGH with whole chromosomeConcerning the third pregnancy, fetal sex was deter-
mined on maternal blood sample at 11 weeks of gesta-
tion, and shown to be female. Ultrasound examinations
were performed at 12, 22 and 32 weeks of gestation and
did not show any abnormality. A girl was vaginally de-
livered at 39 weeks, and the neonatal period was un-
eventful. This girl is now 15 months old and is growing
normally. She has been able to walk at 13 months. Un-
fortunately, the girl was not available for further cyto-
genetic explorations.
Taking into consideration that the asymptomatic mother
carried the aberrant X chromosome inherited by the pro-
band and by the male fetus aborted upon a subsequent
pregnancy, X-inactivation assay was performed on the
mother by analyzing the human androgen receptor CAG re-
peat polymorphism [14]. Results showed that she was
homozygote for the androgen receptor polymorphism so we
were not able to conclude on her X-inactivation pattern.
Conclusions
Here we report two familial interstitial deletions of
Xp11.22 in the same X chromosome of the same patient
presenting with hydrocephalus, severe growth and psy-
chomotor retardation, renal proximal tubulopathy with(A) and the two consecutive and interstitial Xp11.22 deletions (B).





Length Count of gene symbols Gene Symbols
Xp11.22 49,823,986-49,971,921 147936 2 AKAP4, CLCN5
Xp11.22 50,070,457-52,693,963 2623507 23 BMP15, CCNB3, CENPVP1, CENPVP2, DGKK,
GSPT2, MAGED1, MAGED4, MAGED4B, NUDT10,
NUDT11, SHROOM4, SNORA11D, SNORA11E,
SSX7, SSX8, XAxGE1A, XAGE1B, XAGE1C, XAGE1D,
XAGE1E, XAGE2, XAGE2B
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aminoaciduria, hypophosphatemia and hyperuricemia.
Maternal transmission of the deletions was also con-
firmed in a second fetus who was aborted due to the
causality of the deletions.
So far, 11 cases of Xp11.22 deletions in 4 families have
been described [7-10]. The patients’ deletions involving
this region presented a unique deletion often associated
with autism spectrum disorders, variable degrees of ID,
craniofacial dysmorphism, long hands and fingers, nor-
mal growth parameters and significant language delay
[7]. The genomic positions of these previously described
deletions did not overlap with ours. Two other cases de-
scribed in DECIPHER database concerned deletions that
were much smaller than our patient’s deletions. These
patients presented ID and short seizures. Thus, to our
knowledge, this is the first case of two deletions in the
same chromosomal region Xp11.22 associated with se-
vere psychomotor retardation and renal tubulopathy.
Among the genes partially or totally included in the
deletions, SHROOM4 and CLCN5 are candidate genesFigure 2 Evidence on FISH analysis of the Xp11.22 deletions in
the patient (A, C) and his mother (B, D) lymphocytes attested
by the absence of one red signal on metaphase spread for the
BAC clone RP3-519 N18 for the first deletion (control BAC clone
RP11-122 F2 in green) and for the BAC clone RP11-637B23 for
the second deletion (control BAC clone RP11-258C19 in green).whose total loss of expression could explain clinical
manifestations. Severe ID is one of the major sign that
presented our patient. In 2006, Hagens et al., investi-
gated the breakpoints of two balanced X;autosome
translocations in two unrelated female patients with
mild/moderate syndromic ID and found that the Xp11.2
breakpoints disrupt SHROOM4 in both cases [15]. They
also identified a missense exchange in this gene, segre-
gating with the Stocco dos Santos XLMR syndrome in a
large four-generation pedigree but absent in more than
1000 control X-chromosomes. Among other phenotypic
characteristics, the affected males in this family pre-
sented with severe ID, delayed or no speech, seizures
and hyperactivity.
Yoder and Hildebrand described the characterization of
mouse SHROOM4 and observed that the protein localizes
to a distinct population of F-actin and appears to regulate
the formation of this cytoskeletal compartment [16]. My-
osin II is also localized to this compartment and appears
to be required for maintaining its proper organization.
Thus, SHROOM4 encodes a protein involved in cytoskel-
etal architecture and may function to regulate cellular and
cytoskeletal architecture by modulating the spatial distri-
bution of myosin II [16]. SHROOM4 is also expressed in
human adult and fetal brain structures and is needed to
establish or maintain a particular cytoskeletal structure
that is necessary for the function or survival of a specific
neuronal population of cells [16]. These data suggest that
SHROOM4 is important in cognitive function and/or de-
velopment. SHROOM4 is included in the distal Xp11.22
deletion of our patient. The total loss of function could be
responsible for his phenotype. Screening of many more
XLMR patients is also warranted to further confirm the
implication of this gene in XLMR. This could include cel-
lular properties such as morphology, vesicular trafficking
or polarity, all of which are regulated by the actin cytoskel-
eton. Based on these observations, it will be important to
determine what other developmental processes might be
regulated by SHROOM4 and if there are genetic interac-
tions between SHROOM4 and other regulators of cellular
morphology.
Others genes could be potentially candidate for the ID
of the patient. Indeed, western blot analysis of MAGED1
detected expression in embryos, especially in cerebral
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the central nervous system in both developmental and
adult stages [17].
CLCN5 (chloride channel 5) is located on chromo-
some Xp11.22 and encodes CIC-5, member of the CIC
family (chloride ion channels and ion transporters). CIC-
5 is a Cl-/H+ exchanger that is primarily localized to
endosomal membranes and may function to facilitate
reabsorption by the renal proximal tubule [18,19]. Muta-
tions in CLCN5 have been found in Dent disease, an
X-linked inherited renal condition characterized by pro-
teinuria, hypercalciuria and hyperphosphaturia, kidney
stones, and in some cases, kidney failure [11-13].
To date, mutations in the gene are described and alter-
natively spliced transcript variants encoding different iso-
forms have been found. The total number of reported
CLCN5 mutations is 148, and these are scattered through-
out the coding region, with no evidence for major muta-
tional hot spots [20]. The majority of the mutations are
predicted to result in truncated or absent ClC-5 protein,
which would lead to complete loss of Cl-/H+ exchanger
function. There is genetic heterogeneity for Dent disease,
with approximately 60% of patients having CLCN5 muta-
tions (Dent disease 1), ~15% harboring OCRL1 mutations
(Dent disease 2) and the remaining 25% of patients having
neither CLCN5 nor OCRL1 mutations but possibly defects
in other genes [21]. The possibility that these other genes
may encode some of the proteins (e.g. ClC-4 and cofilin)
that interact with ClC-5 [22] has been investigated but no
mutations in CLCN4 or COFILIN were identified yet [20].
Besides the gene content of the two interstitial dele-
tions and the most plausible candidates, one may not ex-
clude position effects on neighboring genes which are
not included in the deletions.
To our knowledge, this patient is the first description of a
double Xp11.22 deletion causing a CLCN5 disruption and
associated with a such characteristic renal proximal tubulo-
pathy. The diagnosis of Dent disease is usefully based on the
presence of all three of the following criteria: low-molecular-
weight proteinuria, hypercalciuria and at least one of the
following: nephrocalcinosis, kidney stones, hematuria, hypo-
phosphatemia or renal insufficiency. Generally, molecular
genetic testing and the presence of a CLCN5 mutation con-
firm the diagnosis. For our patient, the Xp11.22 deletion in-
cluding CLCN5 and, consequently, the loss of CIC-5
exchanger allowed us to confirm the diagnosis of Dent dis-
ease. The genotype-phenotype correlation was discussed
with the family during genetic counseling. Prenatal diagnosis
was proposed for the second pregnancy and the couple de-
cided, according to the French law, to terminate the preg-
nancy with an affected male.
All findings strongly implicate the inherited Xp11.22 dele-
tions as causative of the described somatic and developmen-
tal phenotypes in the affected male patient. The Xp11.22deletions with loss of CLCN5 gene allowed us to confirm
the diagnostic of Dent disease for our patient. Our results




The patient was the product of the first pregnancy of
healthy and non-consanguineous parents. During this first
pregnancy the first trimester ultrasound showed an in-
creased nuchal translucency (3.2 mm for a 63.1 mm
cranio-caudal length). Prenatal cytogenetic analysis per-
formed on trophoblast cells at 12 weeks of gestation
showed a normal male karyotype. Ultrasound examina-
tions at 18 and 22 weeks of gestation showed recurring
polyhydramnios, and the amniotic fluid has been evacu-
ated three times. A premature membrane rupture oc-
curred at 33 weeks and 2 days of gestation and the child
born by cesarean section due to a breech presentation.
Height, weight, and head circumference were 2280 g (55th
percentile), 43 cm (30th percentile), and 33 cm (90th per-
centile), respectively. The neonate was found to be mildly
hypotonic. During the first 24 hours, polyuria (5 ml/kg/h)
and glycosuria were noted, leading to a weight loss of 15%.
Peripheral infusion was inserted for three days until the
infant was able to be bottle fed. The infant was discharged
at 3 weeks. Since the age of 7 months, this child had
hydrocephalus, which required ventriculocysternostomy
at the age of one year (stenosis of the acqueduct of Syl-
vius), a major growth retardation (−4SD for size and
weight) and an overall severe psychomotor retardation.
Walking was acquired at 4.5 years and language was re-
duced to a few disyllabic words. At the age of four-year-
old, this patient was referred for evaluation of severe
growth retardation associated with both motor and cogni-
tive delays. The child presented a prominent philtrum,
large forehead, retrognathia, thin upper lip and low-set
ears (Figure 3). Moreover, the child presented renal prox-
imal tubulopathy with low-molecular-weight proteinuria,
hypercalciuria, hyperaminoaciduria, hypophosphatemia
and hyperuricemia, as observed in Dent disease.
During the couple’s second pregnancy, the first trimester
ultrasound examination showed an increased nuchal trans-
lucency (4,5 mm for a 58.3 mm cranio-caudal length). After
fetal cytogenetic analysis and according to the French law,
the parents decided to terminate the pregnancy.
During the third pregnancy, fetal sex was determined
on maternal blood sample at 11 weeks of gestation, and
shown to be female. Ultrasound examinations were per-
formed at 12, 22 and 32 weeks of gestation and did not
show any abnormality. A girl was vaginally delivered at
39 weeks, and the neonatal period was uneventful.
Parents showed a normal phenotype and no particular
personal history.
Figure 3 Photograph of the patient at 4 years underlying facial
dysmorphy. Note prominent philtrum, large forehead, retrognathia,
thin upper lip and low-set ears.
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Hybridization (FISH) experiments
Standard and high resolution chromosome analyses were
performed from trophoblast cells and cultured peripheral
lymphocytes of the patient using standard procedures
(G-band by trypsin using Giemsa (GTG), R-band after heat
denaturation and Giemsa (RHG) banding techniques and
Giemsa staining). Fluorescent in situ hybridization (FISH)
analyses were performed on lymphocyte metaphase spreads
of the patient, his parents and his maternal grandmother.
The following probes were used according to manufacturer’s
recommendations: a subtelomeric probe specific for all
chromosomes (Vysis, Downers Grove, USA). Bacterial artifi-
cial chromosome (BAC) clones specific for the Xp11.22
chromosomal region were used to confirm the deletions
(RP3-519 N18, RP11-637B23) and BAC clones were chosen
from the outside of deleted regions (RP11-258C19, RP11-
122 F2) (Bluegnome, Cambridge, UK).
Oligonucleotide based array comparative genomic
hybridization analysis (array-CGH)
Genomic DNA of the patient was isolated from peripheral
blood using a DNeasy Blood and Tissue Kit (Qiagen,
Courtaboeuf, France). The extracted DNA concentration
was estimated using a NanoDrop ND-1000 spectrophotom-
eter (NanoDrop Technologies, Wilmington, DE, USA).
Genomic imbalances were analyzed by array-CGH using
180 K and 244 K oligonucleotide arrays (HU-180 K, Hu-244A, Agilent Technologies, Massy, France). Hybridization
was performed according to the manufacturer’s recom-
mended protocol and as previously described. Captured
images were processed with Feature Extraction software
(10.7.3.1) and data analysis was performed with Genomic
Workbench V5.0.14 (Agilent Technologies). The genomic
positions were determined using the version 19 of the Hu-
man Genome (http://genome.ucsc.edu/). The ADM2 algo-
rithm was used for statistical analysis. Copy number
variations (CNV) were considered significant if they were
defined by three or more oligonucleotides and spanned at
least 40 Kb, contained at least one gene and were not identi-
fied in the Database of Genomic Variants at the Centre for
Applied Genomics (http://projects.tcag.ca/cgi-bin/variation/
gbrowse/hg19/). The Nexus Copy Number Standard edition
software (Proteigene, Saint-Marcel, France) algorithm was
used for statistical analysis, with build 19 of the human gen-
ome (http://genome.ucsc.edu/).
X-inactivation molecular assay
2 μg of native DNA was digested by HpaII FastDigest
enzyme (NewEngland BioLabs, Evry, France). The poly-
morphic locus into the androgen receptor gene (CAG-re-
peat) was PCR-amplified with 6-FAM tagged primers from
both undigested and digested DNA. PCR products were
then separated onto ABI Prism3130 genetic analyzer (Ap-
plied Biosystems, Courtaboeuf, France). The PCR fragment
size and area under the curve were determined in compari-
son with the internal size standard GS500LIZ (Applied Bio-
systems) by GeneMapper software (Applied Biosystems).
X-chromosome inactivation ratio (XCR) was calculated
according to the formulae: (AUC-1D/AUC-1ND)/((AUC-
1D/AUC-1ND) + (AUC-2D/AUC-2ND)) for allele 1 and
(AUC-2D/AUC-2ND)/((AUC-1D/AUC-1ND) + (AUC-2D/
AUC-2ND)) for allele 2 with AUC-1, area under the
curve for allele 1; AUC-2, area under the curve for allele
2; D, digested; and ND, undigested. XCR was considered
as skewed over 80/20 and highly skewed over 90/10.
Experimental research on patients was done according
to French law (R.162-16-7 and R.145-15-4).
Consent
Written informed consent was obtained from the patient's
parents for the publication of this report and any accom-
panying images.
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